Brief: Abionyx Pharma Announces Strategic Partnership With GTP Biologics (Groupe Fareva) And V-Nano (Groupe VBI Therapeutics)
March 25 (Reuters) - Abionyx Pharma SA ABNX.PA :
* STRATEGIC PARTNERSHIP WITH GTP BIOLOGICS (GROUPE FAREVA)
AND
V-NANO (GROUPE VBI THERAPEUTICS)
Source text for Eikon: ID:nNDL2BF7PD
Further company coverage: ABNX.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Abionyx Pharma SA
See all newsBrief: ABIONYX Pharma And OLON Enter Into Strategic Manufacturing Partnership
France's ABIONYX Pharma H1 net loss widens as financial expenses rise
Brief: ABIONYX Pharma H1 EBIT EUR -2.27 Million
Abionyx jumps as Stifel starts coverage with 'buy'
Cardiovascular drug developer ABIONYX Pharma's H1 revenue falls